These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19097558)

  • 21. RSV: protecting the littlest patients.
    Lauts NM
    RN; 2005 Dec; 68(12):46-51; quiz 52. PubMed ID: 16411554
    [No Abstract]   [Full Text] [Related]  

  • 22. Health plan medical director: considerations for prevention and management of RSV disease.
    Tzeel A
    Manag Care; 2008 Nov; 17(11 Suppl 12):15-7, discussion 18-9. PubMed ID: 19097559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of RSV: implications for managed care.
    Makari D; Hoopes JM; White N
    Manag Care; 2009 Jan; 18(1 Suppl 2):2-7. PubMed ID: 19230529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze.
    Stensballe LG; Ravn H; Kristensen K; Agerskov K; Meakins T; Aaby P; Simões EA
    J Allergy Clin Immunol; 2009 Feb; 123(2):398-403. PubMed ID: 19101023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33-35 completed weeks' gestational age in Canada.
    Paes B; Steele S; Janes M; Pinelli J
    Curr Med Res Opin; 2009 Jul; 25(7):1585-91. PubMed ID: 19469698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Respiratory syncytial virus infection in adults.
    Murata Y; Falsey AR
    Antivir Ther; 2007; 12(4 Pt B):659-70. PubMed ID: 17944273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of the respiratory syncytial virus risk-scoring tool in the term infant in Canada.
    Paes B; Cole M; Latchman A; Pinelli J
    Curr Med Res Opin; 2009 Sep; 25(9):2191-6. PubMed ID: 19604126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variation in timing of respiratory syncytial virus outbreaks: lessons from national surveillance.
    Panozzo CA; Fowlkes AL; Anderson LJ
    Pediatr Infect Dis J; 2007 Nov; 26(11 Suppl):S41-5. PubMed ID: 18090199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hospitalization for respiratory syncytial virus infection and invasive pneumococcal disease in Danish children aged <2 years: a population-based cohort study.
    Stensballe LG; Hjuler T; Andersen A; Kaltoft M; Ravn H; Aaby P; Simoes EA
    Clin Infect Dis; 2008 Apr; 46(8):1165-71. PubMed ID: 18444851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The causal direction in the association between respiratory syncytial virus hospitalization and asthma.
    Stensballe LG; Simonsen JB; Thomsen SF; Larsen AM; Lysdal SH; Aaby P; Kyvik KO; Skytthe A; Backer V; Bisgaard H
    J Allergy Clin Immunol; 2009 Jan; 123(1):131-137.e1. PubMed ID: 19130934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory syncytial virus infection in elderly and high-risk adults.
    Falsey AR
    Exp Lung Res; 2005 Sep; 31 Suppl 1():77. PubMed ID: 16395866
    [No Abstract]   [Full Text] [Related]  

  • 32. The burden of respiratory syncytial virus bronchiolitis on a pediatric inpatient service.
    Eidelman AI; Megged O; Feldman R; Toker O
    Isr Med Assoc J; 2009 Sep; 11(9):533-6. PubMed ID: 19960846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults > or =65 years of age.
    Langley JM; Sales V; McGeer A; Guasparini R; Predy G; Meekison W; Li M; Capellan J; Wang E
    Vaccine; 2009 Sep; 27(42):5913-9. PubMed ID: 19651171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study finds RSV #1 cause of hospitalization for children under one.
    Pa Nurse; 2002; 57(8):4. PubMed ID: 12514814
    [No Abstract]   [Full Text] [Related]  

  • 35. A novel active respiratory syncytial virus surveillance system in the United States: variability in the local and regional incidence of infection.
    Boron ML; Edelman L; Groothuis JR; Malinoski FJ
    Pediatr Infect Dis J; 2008 Dec; 27(12):1095-8. PubMed ID: 18989237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respiratory syncytial virus infection in adults.
    Murata Y
    Curr Opin Pulm Med; 2008 May; 14(3):235-40. PubMed ID: 18427247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for respiratory syncytial virus hospitalisation in children with heart disease.
    Kristensen K; Stensballe LG; Bjerre J; Roth D; Fisker N; Kongstad T; Svendsen AL; Nielsen BW
    Arch Dis Child; 2009 Oct; 94(10):785-9. PubMed ID: 19541682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Respiratory syncytial virus prophylaxis among preterm infants--four seasons' experience].
    Klimek M; Kwinta P; Kruczek P; Pietrzyk JJ
    Przegl Lek; 2009; 66(1-2):34-8. PubMed ID: 19485253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Usefulness of different risk factor associations in predicting admissions due to respiratory syncytial virus in premature newborns of 32 to 35 weeks gestation in Spain].
    Figueras-Aloy J; Quero-Jiménez J; Fernández-Colomer B; Guzmán-Cabañas J; Echaniz-Urcelay I; Doménech-Martínez E;
    An Pediatr (Barc); 2009 Jul; 71(1):47-53. PubMed ID: 19524492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rate-difference method proved satisfactory in estimating the influenza burden in primary care visits.
    Jansen AG; Sanders EA; Wallinga J; Groen EJ; van Loon AM; Hoes AW; Hak E
    J Clin Epidemiol; 2008 Aug; 61(8):803-12. PubMed ID: 18495428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.